Wednesday, January 19, 2022

    Latest Posts

    Less than 1 in 5 adults with type 2 diabetes in the US are meeting optimal heart health targets

    Credit: AIXabay / CC0 public domain

    In the United States, less than one in five adults with type 2 diabetes meet their goals to reduce their risk of heart disease. Fortunately, according to a new American Heart Association scientific statement published today in the American Heart Association’s flagship journal, available treatments are new to address social determinants of health and other care barriers. Useful when combined with an approach. circulation.. The scientific statement is an analysis by current research experts and may be useful for future clinical practice guidelines.

    “This new scientific statement is a call for urgent action to follow a state-of-the-art evidence-based approach to advance the treatment and care of type 2 diabetes and develop new best practices to mitigate the risk of CVD.” FAHA’s MPH, MD, Joshua J. Joseph said. He is the chair of the statement-making group and assistant professor of medicine at the Department of Endocrinology, Diabetes, and Metabolism at The Ohio State University School of Medicine in Columbus, Ohio. “A very small number of people, less than 20% of people with type 2 diabetes, have successfully managed them. Risk of heart disease, And too many people are having a hard time quitting smoking and losing weight. This is two important CVD risk factors. Healthcare specialist, Healthcare industry And all of the broader community organizations play an important role in helping people with type 2 diabetes. “

    Type 2 diabetes is the most common form of diabetes, affecting more than 34 million people in the United States, and the US Center for Disease Control and Prevention’s 2020 National Diabetes Statistics Report and Cardiovascular Disease (CVD) are type 2 diabetes. It is the main cause of death and disability in people with (T2D). Type 2 diabetes occurs when the body cannot use insulin efficiently or when the pancreas loses its ability to produce insulin. People with type 2 diabetes often have risk factors for other cardiovascular diseases, such as overweight, obesity, high blood pressure, and high cholesterol. Adults with T2D have a heart attack, stroke, heart failure—Compared to adults who do not have T2D.

    A new scientific statement based on an extensive review by the writing group of clinical trial results up to June 2020 provides existing evidence on the best ways to reduce cardiovascular risk in people with type 2 diabetes and the reality of people with type 2 diabetes. Addressing the gap. Goals to reduce the risk of cardiovascular disease in patients with type 2 diabetes include management Blood glucose level, Blood pressure and cholesterol levels; Increased physical activity; Healthy nutrition; Obesity and weight management; Do not smoke. Do not drink alcohol; and psychosocial care. Increased adherence to the overall healthy lifestyle of people with type 2 diabetes significantly reduces the risk of CVD and CVD mortality.

    “In the United States, less than one in five adults with T2D who have not been diagnosed with cardiovascular disease quit smoking and achieve healthy levels of blood sugar, blood pressure, and low-density lipoprotein (LDL) cholesterol. We have achieved our optimal T2D management goals, as “bad” cholesterol, “Joseph said.

    A surprisingly large percentage (as high as 90%) of the factors that effectively manage CVD in T2D include variable lifestyle and social factors. “Social determinants of health, including health-related behaviors, socio-economic factors, environmental factors, and structural racial discrimination, are recognized to have a profound impact on the outcome of cardiovascular disease and type 2 diabetes. “He said. “Patients with type 2 diabetes face many health barriers, such as access to care and impartial care, that must be considered when developing a personalized care plan with the patient.”

    Sharing decisions among patients Healthcare professional Essential for good management of T2D and CVD. A comprehensive diabetes care plan should be tailored to patient preferences based on individual risks and benefits. Potential Cost Concerns; Support for Effectively Managing T2D and Taking Prescribed Medications, including Self-Management Education and Support for Diabetes. Promote and support healthy lifestyle choices that improve cardiovascular health, including nutrition and physical activity. Treatment of other CVD risk factors.

    “One way to tackle and advance diabetes management is to break through the four barriers of a clinic or hospital through community engagement, clinic-community connections, and academic and government partnerships. Physical activity, nutrition, As a quitting and stress management. “

    The statement also highlights recent evidence of T2D treatment that may encourage clinicians and patients to review and update their T2D management plans to address CVD risk factors as well.

    A new way to control blood sugar

    Just as the American Heart Association’s final scientific statement on blood glucose control has begun to suggest that studies may begin to suggest that hypoglycemic agents may reduce the risk of heart attack, stroke, heart failure, or cardiovascular death. , Was announced in 2015.

    “Since 2015, many important national and international clinical trials have been completed specifically examining new T2D drugs to reduce the risk of cardiovascular disease and cardiovascular mortality in patients with type 2 diabetes,” Joseph said. Mr. says. “GLP-1 (glucagon-like peptite-1) receptor agonists have been shown to improve blood sugar and body weight and have become game changers in reducing the risk of heart disease, stroke, heart failure and kidney disease. GLP-1 drugs (injectable synthetic hormones such as liraglutide and semaglutide) stimulate the release of insulin to control blood sugar levels, reduce appetite, and help people feel full. This can help with weight management and weight loss.

    In addition, SGLT-2 (sodium-glucose cotransporter 2) inhibitors (oral drugs such as canagliflozin, dapagliflozin, ertugliflozin, and empagliflozin) are also effective in reducing the risk of CVD and chronic kidney disease. It turns out to be the target. SGLT-2 inhibitors spur the kidneys and process excess glucose through the urine. This reduces the risk of heart failure and slows down the decline in renal function that is common in people with type 2 diabetes.

    “Costs may be a barrier to taking some prescribed type 2 diabetes medications, but many of these medications are now more commonly covered by more health insurance plans.” Said Joseph. “Another barrier is the patient’s perception that these new T2D drugs are also effective in reducing the risk of heart disease, stroke, heart failure and kidney disease. The general perception of the association between CVD and T2D. Raise awareness, provide support, education, and tools. Improving T2D and reducing CVD risk are central. Knowing diabetes from the bottom of your heart Initiatives from the American Heart Association and the American Diabetes Association. “

    Personalized blood pressure control

    The statement highlights an individual approach to treatment High blood pressure it’s the best. With these approaches, it is necessary to consider ways to minimize the side effects of hypertension treatment and avoid the possibility of over-treating frail patients.

    The Importance of Lowering Cholesterol Levels

    Statins continue to be at the forefront of lipid-lowering therapy, and the association is considering other types of drugs for those who cannot tolerate statins or who do not meet the LDL cholesterol target with statins. I am proposing to do it. These drugs may include ezetimibe, benpodic acid, bile acids, fibrates, and PCSK-9 inhibitors, depending on the individual’s overall health and other health conditions.

    Rethink the use of aspirin

    Older people (aged 65 and older) with T2D are more likely to take lower doses of aspirin daily for prophylaxis than adults without T2D. Cardiovascular disease.. However, it may be time to consider whether daily low-dose aspirin is still appropriate. A recently published study found that the increased risk of major bleeding from aspirin could outweigh the benefits, and newer and more potent antiplatelet drugs could be more effective for some people. Suggests.

    This statement underscores the importance of a comprehensive, interdisciplinary and personalized approach to reducing the risk of CVD in patients with type 2 diabetes. Optimal care should incorporate healthy lifestyle interventions and medications and / or treatments, including surgery to improve T2D management and support healthy weight and weight loss. Social determinants of health, structural racism, and fairness of health are important factors that must be considered and addressed.

    The scientific statement was made by a group of volunteer writings on behalf of the Diabetes Committee of the American Heart Association’s Council on Lifestyle and Cardiac Metabolism Health. Council on arteriosclerosis, thrombosis and vascular biology. Clinical Cardiology Council; and Hypertension Council. The American Heart Association’s scientific statement helps raise awareness of cardiovascular disease and stroke issues and facilitates informed medical decisions. The scientific statement outlines what is currently known about the topic and areas that require additional research. Scientific statements inform the development of guidelines, but do not recommend treatment. The American Heart Association guidelines provide the association’s official clinical practice recommendations.

    Co-authors are Vice-Chair Prakash Deedwania, MD and FAHA. Tushar Acharya, MBBS, MPH; David Aguilar, MD, M.Sc., FAHA; Deepak L. Bhatt, MD, MPH, FAHA; Dr. Deborah A. Tune, RN, FAHA; Catherine E. Diparo, Pharm. D. , FAHA; Sherita H. Golden, MD, MHS, FAHA; and Lawrence S. Sparring, MD, FAHA. The author’s disclosure is in the manuscript.

    People with type 2 diabetes should prioritize prevention of heart disease

    For more information:
    circulation (2022). DOI: 10.1161 / CIR.0000000000001040

    Quote: Less than 1 in 5 adults with type 2 diabetes in the United States has an optimal heart obtained from on January 10, 2022. We have achieved our health goal (January 10, 2022). -heart-health.html

    This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.

    Less than 1 in 5 adults with type 2 diabetes in the US are meeting optimal heart health targets Source link Less than 1 in 5 adults with type 2 diabetes in the US are meeting optimal heart health targets

    The post Less than 1 in 5 adults with type 2 diabetes in the US are meeting optimal heart health targets appeared first on California News Times.

    Latest Posts

    Don't Miss

    Stay in touch

    To be updated with all the latest news, offers and special announcements.